logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Z

Zhisong He

 department of urology
H指数:36
被引数:4,437

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nivolumab (NIVO) plus gemcitabine-cisplatin (GC) vs GC alone for previously untreated unresectable or metastatic urothelial carcinoma (u/mUC): Chinese population analysis results from the phase III CheckMate 901 trial

纳武利尤单抗（NIVO）联合吉西他滨-顺铂（GC）对比GC单药治疗既往未接受治疗的不可切除或转移性尿路上皮癌（u/mUC）的III期CheckMate 901试验中国人群分析结果

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Ye, D.; He, Z.; Zou, Q.; Wang, Z.; Xu, D.; Zhang, P.; Dong, H.; Liu, Z.; Guo, J.; Cao, X.; Yuan, X.; Chen, J.; Hu, Y.; Tsai, Y-C.; Kang, W.; Filian, J.; Wang, L.; Luo, H.
Nivolumab plus gemcitabine-cisplatin versus gemcitabinecisplatin alone for previously untreated unresectable or metastatic urothelial carcinoma: Results from the phase III CheckMate 901 trial
ANNALS OF ONCOLOGY
IF65.4
2023-10-018
OAAI
van der Heijden, M. S.; Sonpavde, G. P.; Powles, T. B.; Necchi, A.; Burotto, M.; Schenker, M.; Sade, J. P.; Bamias, A.; Beuzeboc, P.; Bedke, J.; Oldenburg, J.; Urun, Y.; Ye, D.; He, Z.; Valderrama, B. Perez; Tomita, Y.; Filian, J.; Purcea, D.; Nasroulah, F.; Galsky, M. D.
RENOTORCH: Toripalimab combined with axitinib versus sunitinib in first-line treatment of advanced renal-cell carcinoma (RCC) - A randomized, open-label, phase III study

RENOTORCH: Toripalimab联合阿西替尼与舒尼替尼在晚期肾细胞癌 (RCC) 一线治疗中的比较-一项随机，开放标签，III期研究

ANNALS OF ONCOLOGY
IF65.4
2023-10-012
PRE
Sheng, X.; Ye, M.; Zou, Q.; Chen, P.; He, Z.; Wu, B.; He, D.; He, C.; Xue, X.; Ji, Z.; Chen, H.; Zhang, S.; Liu, Y.; Zhai, W.; Zhang, X.; Fu, C.; Xu, D.; Qiu, M.; Huang, Y.; Guo, J.
SAVE Testis-sparing score: a multicenter retrospective study of a novel predictive tool for quantifying testicular tumors
INTERNATIONAL JOURNAL OF SURGERY
IF10.1
2023-09-220
OAAI
Liu, Zhenhua; Xie, Junyi; Gao, Xiaofeng; Lin, Yuan; Sun, Mengkui; Sun, Yubo; Peng, Ding; Xie, Haibiao; Li, Xiangdong; Li, Zhiyong; Cai, Taonong; Chen, Pengyu; Wu, Zhiming; Guo, Shengjie; Li, Yonghong; Zhang, Zhilin; Qin, Zike; Han, Hui; He, Zhisong; Liu, Jiumin; Fu, Wen; Li, Shoulin; Xia, Dan; Wang, Xiang; Deng, Chunhua; Xu, Zhe; Zhou, Fangjian; Yao, Kai; Yu, Wei; Ye, Yunlin; Liu, Zhuowei
Lugol-unstained lesions location in the esophagus affects the detection rate of malignancy: a population-based study

食管中Lugol未染色病变的位置影响恶性肿瘤的检出率: 一项基于人群的研究

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
IF3.4
2023-09-192
PRE
Qin, Jing; Liu, Mengfei; Liu, Anxiang; Guo, Chuanhai; Qi, Zifan; Zhou, Ren; Yang, Haijun; Li, Fenglei; Duan, Liping; Shen, Lin; Wu, Qi; Liu, Zhen; Pan, Yaqi; Liu, Fangfang; Liu, Ying; Cai, Hong; He, Zhonghu; Ke, Yang
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
EUROPEAN JOURNAL OF CANCER
IF7.1
2023-01-0110
PRE
Sheng, Xinan; Ye, DingWei; Zhou, Aiping; Yao, Xin; Luo, Hong; He, Zhisong; Wang, Zengjun; Zhao, Yingchao; Ji, Zhigang; Zou, Qing; He, Chaohong; Guo, Jianming; Tu, Xinhua; Liu, Ziling; Shi, Benkang; Liu, Ben; Chen, Peng; Wei, Qiang; Hu, Zhiquan; Zhang, Yanqiao; Jiang, Kui; Zhou, Fangjian; Wu, Dapeng; Fu, Cheng; Li, Xingya; Wu, Bin; Wang, Lijie; Qin, Shukui; Li, Gang; Liu, Yunpeng; Guo, Hongqian; Chen, Kehe; Zhang, Dahong; Wang, Gongxian; Ding, Lieming; Wang, Yang; Yuan, Xiaobin; Guo, Jun
What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy?
EUROPEAN UROLOGY
IF25.2
2022-05-0125
PRE
Xiong, Longbin; Nguyen, Jane K.; Peng, Yulu; Zhou, Zhaohui; Ning, Kang; Jia, Nan; Nie, Jing; Wen, Dongxiang; Wu, Zeshen; Roversi, Gustavo; Palacios, Diego Aguilar; Abramczyk, Emily; Munoz-Lopez, Carlos; Campbell, Jack A.; Cao, Yun; Li, Wencai; Zhang, Xuepei; He, Zhisong; Li, Xiang; Huang, Jiwei; Shou, Jianzhong; Wu, Jitao; Chen, Minfeng; Chen, Xiaofeng; Zheng, Jiaxuan; Xu, Congjie; Zhong, Wen; Li, Zaishang; Dong, Wen; Zhao, Juping; Zhang, Hailang; Luo, Junhang; Liu, Jianye; Sun, Fanghu; Han, Hui; Guo, Shengjie; Dong, Pei; Zhou, Fangjian; Yu, Chunping; Campbell, Steven C.; Zhang, Zhiling
Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell Carcinoma

平均红细胞血红蛋白，纤维蛋白原和白蛋白 (mf-a) 的组合是可切除食管鳞状细胞癌患者的新型预后指标

ANNALS OF SURGICAL ONCOLOGY
IF3.5
2022-02-185
PRE
Liang, Linlin; Liu, Fangfang; Yang, Wenlei; Yang, Wei; Chen, Lei; He, Yu; Liu, Zhen; Zhang, Liqun; Zhang, Fan; Cai, Fen; Xu, Huawen; Lin, Miaoping; Liu, Mengfei; Pan, Yaqi; Liu, Ying; Hu, Zhe; Chen, Huanyu; He, Zhonghu; Ke, Yang

研究方向

暂未获取到该数据
周利群 封面图
周利群
H 指数:46论文数:687被引数:8,529
Y
Yaqi Pan
H 指数:26论文数:132被引数:1,913
刘方方 封面图
刘方方
H 指数:24论文数:166被引数:2,369
M
Mengfei Liu
H 指数:24论文数:139被引数:1,926
H
Hong Cai
H 指数:35论文数:241被引数:5,094
X
Xuesong Li
H 指数:38论文数:533被引数:5,416
C
Chuanhai Guo
H 指数:26论文数:145被引数:2,799
G
Gengyan Xiong
H 指数:22论文数:112被引数:1,460
Y
Ying Liu
H 指数:21论文数:85被引数:1,357
杨
杨克
H 指数:56论文数:546被引数:1.1万